CORONAVIRUS/Rollout of domestic COVID-19 vaccine likely by August: CECC

07/28/2021 08:29 PM
To activate the text-to-speech service, please first agree to the privacy policy below.
CNA file photo
CNA file photo

Taipei, July 28 (CNA) A domestic COVID-19 vaccine that has been included as an option on the government's online vaccination appointment system is expected to be available by August, Minister of Health and Welfare Chen Shih-chung (陳時中) said Wednesday.

Chen made the remarks at a press briefing, after President Tsai Ing-wen (蔡英文) said earlier in the day that she had registered to get the COVID-19 vaccine developed by Taiwan-based Medigen Vaccine Biologics Corp.

"I've registered online to get #Taiwan's domestically developed Medigen COVID-19 vaccine," Tsai tweeted.

Chen announced on July 19 that the Taiwan Food and Drug Administration (FDA) had granted emergency use authorization (EUA) for the Medigen vaccine to begin mass production.

Noting that Tsai has registered on the government's online registration system to get the Medigen vaccine, Chen said Wednesday that when the vaccine becomes available, most likely in August, the president will be able to book an appointment.

More information about the Medigen vaccine will soon be posted on the website of the Central Epidemic Command Center (CECC), said Chen, who heads the center.

Meanwhile, Vice President Lai Ching-te (賴清德) is planning to get a COVID-19 vaccine developed by another Taiwanese manufacturer, United Biomedical Inc. Asia, once it receives EUA from the Taiwan FDA, according to Chen.

(By Chen Chieh-ling, Chiang Hui-chun and Evelyn Kao)


Note: Taiwan
Note: Taiwan's vaccine rollout began on March 22, first with doses from AstraZeneca, then the Moderna ones on June 9.
View All
We value your privacy.
Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.